Floatz logo

Ladarixin

Advanced Non-small Cell Lung Cancer With KRAS G12C Mutation

NYU Langone HealthPhase 2
Rating in progress

Ladarixin in Advanced Non-small Cell Lung Cancer With KRAS G12C Mutation is in the Floatz rating universe. The engine has not yet published a v0.2 rating for this asset. This page will update automatically once scoring completes.

Methodology v0.2 · Active